Scholarlink

Inflammation is a physiological process that plays a key role in combating infections and promoting healing. However, when dysregulated, it can lead to the development of chronic diseases. This dysregulation is particularly evident in tumor environments, where cancer cells exploit inflammation to evade the immune system. Specifically, cancer cells release inflammatory molecules that support their growth and resistance, with cyclooxygenases (COXs) and matrix metalloproteinases (MMPs) being major contributors to this process. According to research, the dysregulation of COX-2 is linked to tumor progression, while MMPs, particularly MMP-3 and MMP-13, are associated with cancer invasion and metastasis. Although current treatments, such as COX-2 inhibitors, are available, there remains a need for more effective therapies with fewer side effects. In this context, the present study focuses on identifying specific inhibitors of MMPs, especially MMP-3 and MMP-13, due to their critical roles in tumor progression. Notably, it examines the therapeutic potential of turmeric (Curcuma longa), a plant known for its antioxidant, anti-inflammatory, and anticancer properties. Through in silico molecular docking, this study evaluates the interactions of Curcuma longa derivatives with COX-2, MMP- 3, and MMP-13, aiming to identify compounds with potential immunoregulatory activity for the treatment of inflammatory and cancer-related diseases.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prediction Through Molecular Docking Technique Between Secondary Metabolites Reported for Curcuma Longa with Proteins Involved in Chronic Inflammatory Processes

  • 会议论文

  • 发表日期：

    2025年

查看全文
  • Adrián J. Villacob Martínez,
  • Elkin E. Sanabria Chanaga,
  • Sandra S. Arango Varela

摘要

Inflammation is a physiological process that plays a key role in combating infections and promoting healing. However, when dysregulated, it can lead to the development of chronic diseases. This dysregulation is particularly evident in tumor environments, where cancer cells exploit inflammation to evade the immune system. Specifically, cancer cells release inflammatory molecules that support their growth and resistance, with cyclooxygenases (COXs) and matrix metalloproteinases (MMPs) being major contributors to this process. According to research, the dysregulation of COX-2 is linked to tumor progression, while MMPs, particularly MMP-3 and MMP-13, are associated with cancer invasion and metastasis. Although current treatments, such as COX-2 inhibitors, are available, there remains a need for more effective therapies with fewer side effects. In this context, the present study focuses on identifying specific inhibitors of MMPs, especially MMP-3 and MMP-13, due to their critical roles in tumor progression. Notably, it examines the therapeutic potential of turmeric (Curcuma longa), a plant known for its antioxidant, anti-inflammatory, and anticancer properties. Through in silico molecular docking, this study evaluates the interactions of Curcuma longa derivatives with COX-2, MMP- 3, and MMP-13, aiming to identify compounds with potential immunoregulatory activity for the treatment of inflammatory and cancer-related diseases.